Overview

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is to evaluate the end of treatment effect of Daglutril compared to placebo on top of losartan.
Phase:
Phase 2
Details
Lead Sponsor:
Solvay Pharmaceuticals
Treatments:
Losartan